Pharma Mar (XMAD:PHM) Gross Margin % : 95.35% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Pharma Mar's Gross Profit for the three months ended in Mar. 2024 was €36.2 Mil. Pharma Mar's Revenue for the three months ended in Mar. 2024 was €38.0 Mil. Therefore, Pharma Mar's Gross Margin % for the quarter that ended in Mar. 2024 was 95.35%.

The historical rank and industry rank for Pharma Mar's Gross Margin % or its related term are showing as below:

XMAD:PHM' s Gross Margin % Range Over the Past 10 Years
Min: 75.7 Med: 92.95 Max: 95.47
Current: 94.3

During the past 13 years, the highest Gross Margin % of Pharma Mar was 95.47%. The lowest was 75.70%. And the median was 92.95%.

XMAD:PHM's Gross Margin % is ranked better than
91.9% of 741 companies
in the Biotechnology industry
Industry Median: 59.43 vs XMAD:PHM: 94.30

Pharma Mar had a gross margin of 95.35% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Pharma Mar was -0.40% per year.

Pharma Mar Gross Margin % Historical Data

The historical data trend for Pharma Mar's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Gross Margin % Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

93.91

94.92

92.85

93.05

93.92

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross Margin %	Get a 7-Day Free Trial															93.73	95.91	91.60	93.95	95.35

Competitive Comparison of Pharma Mar's Gross Margin %

For the Biotechnology subindustry, Pharma Mar's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Mar's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Gross Margin % falls into.

Pharma Mar Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Pharma Mar's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	148.5	/	158.153
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(158.153 - 9.613)	/	158.153
	=	93.92 %

Pharma Mar's Gross Margin for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )	=	Gross Profit (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	36.2	/	37.966
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(37.966 - 1.765)	/	37.966
	=	95.35 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Pharma Mar (XMAD:PHM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Pharma Mar had a gross margin of 95.35% for the quarter that ended in Mar. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Pharma Mar Gross Margin % Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.